enfortumab,enfortumab vedotin
astellas,seagen
['urothelial carcinoma', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'ev-301', 'enfortumab', 'urothelial', 'seagen']
24-month findings from the phase 3 trial of enfortumab vedotin versus #chemotherapy in patients with previously treated advanced urothelial carcinoma. don't miss presenting long-term outcomes in ev-301 today at 4:30 pm in arie crown. #asco22 #gu
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements